vs

Side-by-side financial comparison of Local Bounti Corporation (LOCL) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.

OCULAR THERAPEUTIX, INC is the larger business by last-quarter revenue ($13.3M vs $12.5M, roughly 1.1× Local Bounti Corporation). Local Bounti Corporation runs the higher net margin — -69.8% vs -488.0%, a 418.1% gap on every dollar of revenue. On growth, Local Bounti Corporation posted the faster year-over-year revenue change (23.7% vs -22.4%). Local Bounti Corporation produced more free cash flow last quarter ($-3.6M vs $-57.1M). Over the past eight quarters, Local Bounti Corporation's revenue compounded faster (21.9% CAGR vs -5.3%).

Local Bounti Corporation is a U.S.-based sustainable indoor agriculture firm growing fresh, pesticide-free leafy greens, herbs and produce via advanced hydroponic and vertical farming tech. It serves North American retail and food service partners, focusing on low environmental impact and stable year-round supply.

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

LOCL vs OCUL — Head-to-Head

Bigger by revenue
OCUL
OCUL
1.1× larger
OCUL
$13.3M
$12.5M
LOCL
Growing faster (revenue YoY)
LOCL
LOCL
+46.1% gap
LOCL
23.7%
-22.4%
OCUL
Higher net margin
LOCL
LOCL
418.1% more per $
LOCL
-69.8%
-488.0%
OCUL
More free cash flow
LOCL
LOCL
$53.5M more FCF
LOCL
$-3.6M
$-57.1M
OCUL
Faster 2-yr revenue CAGR
LOCL
LOCL
Annualised
LOCL
21.9%
-5.3%
OCUL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LOCL
LOCL
OCUL
OCUL
Revenue
$12.5M
$13.3M
Net Profit
$-8.7M
$-64.7M
Gross Margin
12.2%
88.0%
Operating Margin
-106.1%
-526.5%
Net Margin
-69.8%
-488.0%
Revenue YoY
23.7%
-22.4%
Net Profit YoY
76.0%
-33.6%
EPS (diluted)
$1.52
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LOCL
LOCL
OCUL
OCUL
Q4 25
$12.5M
$13.3M
Q3 25
$12.2M
$14.5M
Q2 25
$12.1M
$13.5M
Q1 25
$11.6M
$10.7M
Q4 24
$10.1M
$17.1M
Q3 24
$10.2M
$15.4M
Q2 24
$9.4M
$16.4M
Q1 24
$8.4M
$14.8M
Net Profit
LOCL
LOCL
OCUL
OCUL
Q4 25
$-8.7M
$-64.7M
Q3 25
$-26.4M
$-69.4M
Q2 25
$-21.6M
$-67.8M
Q1 25
$-37.7M
$-64.1M
Q4 24
$-36.3M
$-48.4M
Q3 24
$-34.3M
$-36.5M
Q2 24
$-25.3M
$-43.8M
Q1 24
$-24.1M
$-64.8M
Gross Margin
LOCL
LOCL
OCUL
OCUL
Q4 25
12.2%
88.0%
Q3 25
11.5%
87.8%
Q2 25
12.2%
85.6%
Q1 25
12.6%
88.2%
Q4 24
5.4%
92.8%
Q3 24
13.8%
89.9%
Q2 24
14.3%
90.8%
Q1 24
9.4%
91.0%
Operating Margin
LOCL
LOCL
OCUL
OCUL
Q4 25
-106.1%
-526.5%
Q3 25
-149.4%
-472.3%
Q2 25
-127.7%
-502.6%
Q1 25
-135.6%
-597.5%
Q4 24
-166.6%
-296.1%
Q3 24
-176.0%
-298.2%
Q2 24
-146.8%
-265.1%
Q1 24
-122.9%
-214.0%
Net Margin
LOCL
LOCL
OCUL
OCUL
Q4 25
-69.8%
-488.0%
Q3 25
-216.6%
-477.3%
Q2 25
-178.3%
-503.9%
Q1 25
-324.6%
-598.7%
Q4 24
-360.1%
-283.3%
Q3 24
-335.2%
-236.6%
Q2 24
-267.6%
-266.3%
Q1 24
-286.9%
-438.9%
EPS (diluted)
LOCL
LOCL
OCUL
OCUL
Q4 25
$1.52
$-0.27
Q3 25
$-1.18
$-0.38
Q2 25
$-1.63
$-0.39
Q1 25
$-4.32
$-0.38
Q4 24
$-4.24
$-0.25
Q3 24
$-4.01
$-0.22
Q2 24
$-3.00
$-0.26
Q1 24
$-2.89
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LOCL
LOCL
OCUL
OCUL
Cash + ST InvestmentsLiquidity on hand
$4.2M
$737.1M
Total DebtLower is stronger
$483.1M
Stockholders' EquityBook value
$-166.2M
$654.3M
Total Assets
$410.5M
$808.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LOCL
LOCL
OCUL
OCUL
Q4 25
$4.2M
$737.1M
Q3 25
$6.2M
$344.8M
Q2 25
$5.3M
$391.1M
Q1 25
$18.0M
$349.7M
Q4 24
$937.0K
$392.1M
Q3 24
$317.0K
$427.2M
Q2 24
$9.7M
$459.7M
Q1 24
$8.2M
$482.9M
Total Debt
LOCL
LOCL
OCUL
OCUL
Q4 25
$483.1M
Q3 25
$484.9M
Q2 25
$478.3M
Q1 25
$480.0M
Q4 24
$436.8M
Q3 24
$398.4M
Q2 24
$374.0M
Q1 24
$329.8M
Stockholders' Equity
LOCL
LOCL
OCUL
OCUL
Q4 25
$-166.2M
$654.3M
Q3 25
$-158.1M
$258.2M
Q2 25
$-132.7M
$305.9M
Q1 25
$-134.5M
$265.9M
Q4 24
$-100.5M
$315.3M
Q3 24
$-65.6M
$352.0M
Q2 24
$-32.8M
$377.7M
Q1 24
$-9.4M
$408.0M
Total Assets
LOCL
LOCL
OCUL
OCUL
Q4 25
$410.5M
$808.1M
Q3 25
$417.8M
$410.9M
Q2 25
$426.8M
$451.3M
Q1 25
$447.2M
$405.9M
Q4 24
$428.0M
$457.9M
Q3 24
$430.8M
$490.4M
Q2 24
$438.1M
$517.1M
Q1 24
$413.4M
$538.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LOCL
LOCL
OCUL
OCUL
Operating Cash FlowLast quarter
$-3.1M
$-54.2M
Free Cash FlowOCF − Capex
$-3.6M
$-57.1M
FCF MarginFCF / Revenue
-29.1%
-430.9%
Capex IntensityCapex / Revenue
3.9%
21.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.9M
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LOCL
LOCL
OCUL
OCUL
Q4 25
$-3.1M
$-54.2M
Q3 25
$-8.9M
$-50.7M
Q2 25
$-8.7M
$-55.2M
Q1 25
$-9.6M
$-44.7M
Q4 24
$1.2M
$-39.4M
Q3 24
$-17.2M
$-36.6M
Q2 24
$-4.0M
$-24.8M
Q1 24
$-7.1M
$-33.9M
Free Cash Flow
LOCL
LOCL
OCUL
OCUL
Q4 25
$-3.6M
$-57.1M
Q3 25
$-10.1M
$-56.7M
Q2 25
$-14.6M
$-56.5M
Q1 25
$-14.5M
$-46.6M
Q4 24
$-8.6M
$-39.6M
Q3 24
$-30.0M
$-36.6M
Q2 24
$-28.8M
$-25.5M
Q1 24
$-42.1M
$-34.1M
FCF Margin
LOCL
LOCL
OCUL
OCUL
Q4 25
-29.1%
-430.9%
Q3 25
-82.8%
-390.0%
Q2 25
-121.0%
-419.7%
Q1 25
-125.1%
-435.6%
Q4 24
-85.3%
-232.0%
Q3 24
-293.1%
-237.6%
Q2 24
-305.4%
-155.4%
Q1 24
-501.8%
-231.1%
Capex Intensity
LOCL
LOCL
OCUL
OCUL
Q4 25
3.9%
21.4%
Q3 25
9.7%
41.2%
Q2 25
48.9%
9.3%
Q1 25
42.8%
18.1%
Q4 24
97.6%
1.2%
Q3 24
125.0%
0.6%
Q2 24
263.0%
4.5%
Q1 24
417.3%
1.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons